Orange Ventures invests in French health-tech startup Biolevate in financing round
Bitget2026/09/22 08:01- Orange Ventures invested in French health-tech start-up Biolevate in its latest financing round, taking a minority stake.
- Deal targets life sciences automation, aiming to speed drug development workflows using Biolevate’s agentic AI platform.
- Orange Business will partner with Biolevate, combining its technology with Enovalife’s clinical research, data, and AI transformation services.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Cloud Sector Faces a Key Moment: CoreWeave (CRWV.US) Set to Announce Earnings, Wells Fargo Remains Bullish
CoreWeave (CRWV.US) will release its third-quarter financial report after the U.S. stock market closes on Tuesday. This is seen as a key test for the strength of the new AI cloud sector.
JPMorgan raises target prices for Target and Walmart
Orient Precision Industries Holds Extraordinary Shareholders Meeting
Citi optimistic about international oil companies: low-cost resource reserves being rebuilt may drive energy sector to reverse a decade-long valuation discount
With oil prices in the mid-$70s range, Citi believes that global international oil companies (IOCs) can deliver a free cash flow yield of 7% to 8%, and achieve a real growth rate of 4% to 5% over a period of time.
Crypto prices
More
